Pomalidomide is a drug that belongs toa new generation of antitumor immunomodulators. This substance has the ability to inhibit stromal cells, which support the development and growth of myeloma. In addition, it induces apoptosis (programmed death of defective cells) and inhibits proliferation (proliferation of tissues).
Studies have shown that, thanks to the use of pamildomide, the level of progression is reduced by 52%, and the life expectancy significantly increases.
This substance was approved in the United States for the treatment of refractory multiple and relapsing myeloma. There it is issued under the trade name "Pomalist", and in the EU it is known as "Imnovid".
Before we continue the description of the actionpoamidomide, it should be said that the medications needed in the treatment of cancer are expensive. And the problem for patients is that there is no way to interrupt treatment, and it's very difficult to pay for the whole course. So, in Moscow, on a branded drug containing pologidomide, the price is kept around 819 000 rubles.
In this situation, you will come to the aid of a well-known site . Here you can buy generics,containing the same active substance - pologidomide, the price on them will be much more affordable. And this is due not to the poor quality of the drug, but to the fact that the famous Indian company that produces it did not have to invest in research, development and advertising. She only bought the right to produce the drug, which explains its relatively low cost, with the same efficiency.
Pomalidomide is indicated in the treatment of patients over 18 years of age who have a marked progression of refractory multiple myeloma after at least 2 courses of treatment with lenalidomide and bortezomib.
Apply the drug inside, in conjunction with dexamethasone, 4 mg once a day, for 21 days, after which a break for a week is necessary.
Прием препарата должен проводиться в одни и те же hours, every day, regardless of meal time. To chew or break capsules is impossible. If one treatment was missed, then the next day you do not need to drink a double dose of the drug.
With the progression of the disease, treatment is suspended.
Do not prescribe medications containing pomalidomide, children under 18 years of age and pregnant women. Breastfeeding for the period of treatment with the above remedy should be discontinued.
The condition of patients with renal and hepatic insufficiency should be monitored by the attending physician for the timely detection of an adverse reaction.
When treating drugs containing pomalidomide ("Imovid", "Pomalist", etc.), patients may experience the following negative effects:
